Fall in population-based mortality from coronary heart disease negated in people with diabetes mellitus: Data from England

Diabetic Medicine

Volumn 32, Issue 10, 2015, Pages 1329-1334

  Ecclestone, T C ^a   Yeates, D G R ^a   Goldacre, M J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHILD; DEATH CERTIFICATE; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GROUPS BY AGE AND SEX; HUMAN; INFANT; ISCHEMIC HEART DISEASE; MALE; MIDDLE AGED; NEWBORN; UNITED KINGDOM; CORONARY ARTERY DISEASE; ENGLAND; MORTALITY; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; DEATH CERTIFICATES; DIABETES MELLITUS; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY;

EID: 84941940520     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12770     Document Type: Article

References (20)

1. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-1457.
2. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012; 344: d8059.
3. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101-1107.
4. Townsend N, Wickramasinghe K, Bhatnagar P, Smolina K, Nichols M, Leal J et al. Coronary Heart Disease Statistics. London: British Heart Foundation, 2012.
5. Nichols M, Townsend N, Scarborough P, Rayner M. European Cardiovascular Disease Statistics 4th edition 2012: EuroHeart II. Eur Heart J 2013; 34: 3007.
6. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038.
7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
8. González EL, Johansson S, Wallander MA, Rodríguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 63: 332-336.
9. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40.
10. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
11. Acheson ED. Oxford Record Linkage Study. A central file of morbidity and mortality records for a pilot population. Br J Prev Soc Med 1964; 18: 8-13.
12. O'Flaherty M, Allender S, Taylor R, Stevenson C, Peeters A, Capewell S. The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. Int J Cardiol 2012; 158: 193-198.
13. Duncan ME, Goldacre MJ. Certification of deaths from diabetes mellitus and obesity in England: trends into the twenty-first century. J Public Health 2013; 35: 293-297.
14. Office for National Statistics. Mortality Statistics General (Table 4). Series DH1 no. 38. London: Office for National Statistics, 2007.
15. Office for National Statistics. Deaths Registered in England and Wales in 2010, by Cause. Available at http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics–deaths-registered-in-england-and-wales–series-dr-/2010/index.html Last accessed 20 January 2015.
16. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation 2008; 117: 598-604.
17. Hardoon SL, Morris RW, Thomas MC, Wannamethee SG, Lennon LT, Whincup PH. Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British men. Diabetes Care 2010; 33: 1494-1496.
18. Taylor KS, Heneghan CJ, Farmer AJ, Fuller AM, Adler AI, Aronson JK et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 2013; 36: 2366-2371.
19. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
20. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 237.